View a collection of our latest thoughts on engineering, neuroscience, medicine, and caring for patients with neurological and psychiatric disorders.
Betting big on quantitative neurobiomarkers
Jake Donoghue, MD PhD
- Introducing Beacon Biosignals: a neurotechnology company founded to develop machine learning-enabled EEG neurobiomarkers and accelerate precision medicine for any disease state affecting the brain
- Founded by MD/PhDs and engineers from Harvard and MIT, Beacon is propelled by the vision of a computing platform designed to scale the interrogation of large brain datasets with unprecedented throughput & capability
- Beacon’s EEG neurobiomarker platform is engineered to accelerate clinical trials and enable new treatments for patients with neurological & psychiatric disease